Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.

Objective: Outcome data for patients ≥75 years with hypertrophic obstructive cardiomyopathy (HOCM) undergoing alcohol septal ablation (ASA) are lacking. Therefore, a retrospective single-centre analysis was conducted.

Methods: The data of all consecutive ASAs, that were performed at our institution between 1 September 1997 and 31 July 2021 in patients with HOCM with left ventricular outflow tract gradients (LVOTG) ≥50 mm Hg, were collected from patient reports.

Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Objective: Alcohol septal ablation (ASA) improves symptoms in hypertrophic obstructive cardiomyopathy (HOCM). We conducted a large retrospective analysis investigating gender effects on outcome after ASA.

Methods And Results: 1367 ASAs between 2002 and 2020 were analysed.